🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
Recipient desensitization is a prerequisite for successful ABO-incompatible...
Status
Terminated
Location
Division of Medicine III, Dpt. of Nephrology and Dialysis, Medical University Vienna
Start Date
2014-10
Trial ID
NCT02120482
Treatments Being Tested
The plasma filter is applied for a single use in extracorporeal blood purif...
Status
Recruiting
Location
Klinikum Aschaffenburg-Alzenau
Start Date
2024-07-18
Trial ID
NCT06382675
Treatments Being Tested
Corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange (PE...
Status
Completed
Location
Xuanwu Hospital of Capital Medical University
Start Date
2020-11-25
Trial ID
NCT03542279
This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Start Date
2025-09-01
Trial ID
NCT07117305
Treatments Being Tested
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
This is a multi-site study with plerixafor in pediatric cancer patients. Th...
Status
Completed
Location
Investigational Site Number 51
Start Date
2014-03-03
Trial ID
NCT01288573
Treatments Being Tested
The purpose of this study is to see if two treatments (extracorporeal photo...
Status
Withdrawn
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2024-10-01
Trial ID
NCT05333029
Treatments Being Tested
This phase II trial tests how well adding lisocabtagene maraleucel (liso-ce...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-06-02
Trial ID
NCT05672173
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662